$MEDP
AI分析生成日 May 11, 2026
AI Score
Hold$MEDP
Medpace Holdings
$MEDPNASDAQHealthcareMid-Cap
Medpace is a clinical contract research organization providing drug and medical device development services.
Market Cap
$10.0B
Revenue (TTM)
$2.1B
+12.0%
Net Income (TTM)
$0.35B
+15.0%
EPS (TTM)
$11.00
P/E Ratio
22.0
Dividend Yield
0.0%
52-Week Range
$260-$440
Beta
0.82
Dimension Scores
Fundamental
72Technical
70Sentiment
74Risk / Reward
72Momentum
72Financial Health
Profitability
77strong
Growth
75strong
Liquidity
80strong
Solvency
74strong
Efficiency
70strong
Valuation, technical analysis, investment thesis, risk assessment and more for $MEDP
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。